Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial

Sanne M Dorhout Mees, MD, Ale Algra, MD, W Peter Vandertop, MD, Fop van Kooten, MD, Hans AJM Kuijsten, MD, Jelis Boiten, MD, Robert J van Oostenbrugge, MD, Rustam Al-Shahi Salman, PhD, Pablo M Lavados, MD, Gabriel JE Rinkel, MD, Walter M

van den Bergh, MD and on behalf of the MASH-2 study group

The LancetVolume 380, Issue 9836, Pages 44-49 (July 2012)

DOI: 10.1016/S0140-6736(12)60724-7

Copyright © 2012 Elsevier Ltd Terms and Conditions

Figure 1

Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)

Terms and Conditions

Figure 2

Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)

Terms and Conditions

Figure 3

Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)

Terms and Conditions

Figure 4

Source: The Lancet 2012; 380:44-49 (DOI:10.1016/S0140-6736(12)60724-7)

Terms and Conditions